President & Chief Executive Officer
Martin VanTrieste, President & Chief Executive Officer, Civica Rx, has over 35 years of experience in the pharmaceutical industry, focusing on manufacturing and quality.
He recently retired as Senior Vice President, Quality at Amgen, where he was responsible for quality assurance, quality control, compliance, operational excellence, environment, health and safety along with training. Prior to joining Amgen, Mr. VanTrieste was with Bayer Healthcare’s Biological Products Division as Vice President of Worldwide Quality and Abbott Laboratories as the Vice President of Quality Assurance for the Hospital Products Division. While at Abbott, Mr. VanTrieste held various positions in quality, operations, and research and development. He started his career at Abbott in 1983 after obtaining his pharmacy degree from Temple University School of Pharmacy.
Mr. VanTrieste was the Chairman of the Parenteral Drug Association (PDA) Board of Directors. The PDA represents over 10,000 members and is a global facilitator of scientifically sound, practical technical information, quality systems and expertise to advance pharmaceutical / biopharmaceutical manufacturing science and regulation so members can better serve patients.
He is the founder of Rx-360 and first Chairman of the Board of Directors. Rx-360 is a nonprofit international supply-chain organization that enhances patient safety by increasing the security and quality in the biopharmaceutical supply chain.
Mr. VanTrieste has been actively involved with various professional and trade organizations, including, United States Pharmacopeia, Pharmaceutical Quality Research Institute, Pharmaceutical Research and Manufactures of America (PhRMA), and AdvaMed.
PharmaVoice in 2012 named him as one of the 100 most inspiring people in the pharmaceutical industry, calling him “a man with a mission.” The Medicine Maker in 2016, 2017 and 2018 named him one of the most influential people in the world of drug development and manufacture saying, “he is known throughout industry for his work on advancing quality assurance and helping to ensure a more reliable supply of high-quality medicines.”